Jan 16, 2024 8:00am EST ClearPoint Neuro Announces FDA Clearance for SmartFrame OR™ Stereotactic System
Jan 08, 2024 4:05pm EST ClearPoint Neuro Reports Fourth Quarter and Full Year 2023 Preliminary Revenue Results and Guidance for Full Year 2024 Revenue
May 24, 2023 9:25am EDT ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery
May 18, 2023 4:01pm EDT ClearPoint Neuro to Present at the B. Riley Securities 2023 Institutional Investor Conference
May 10, 2023 4:05pm EDT ClearPoint Neuro to Present Investigational Research and Showcase Novel Innovations at the 26th American Society of Gene & Cell Therapy Annual Meeting in Los Angeles